ProCE Banner Activity

Multiple Myeloma Care Is Changing, and the Treatment Decision Support Tool Is Keeping Pace

Clinical Thought

Read this expert commentary for an overview of our updated treatment decision support tool for multiple myeloma, which provides current treatment recommendations from 5 experts for your patients with multiple myeloma.

Released: June 22, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Partners

Smart Patients

ProCE Banner

Disclosure

Primary Author

Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO

Professor, Clinical Genomics and Therapeutics
Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Chief Medical Officer
International Myeloma Foundation
Phoenix, Arizona

Joseph Mikhael, MD, MEd, FRCPC, FACP: consultant/advisor/speaker: Amgen, Bristol-Myers Squibb, Janssen, Karyopharm, Sanofi, Takeda.